{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T09:24:44Z","timestamp":1773307484827,"version":"3.50.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,6,20]],"date-time":"2017-06-20T00:00:00Z","timestamp":1497916800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81571989"],"award-info":[{"award-number":["81571989"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81171558"],"award-info":[{"award-number":["81171558"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81600471"],"award-info":[{"award-number":["81600471"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81271808"],"award-info":[{"award-number":["81271808"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1007\/s12072-017-9803-4","type":"journal-article","created":{"date-parts":[[2017,6,20]],"date-time":"2017-06-20T08:23:27Z","timestamp":1497947007000},"page":"419-428","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Functional restoration of CD56bright NK cells facilitates immune control via IL-15 and NKG2D in patients under antiviral treatment for chronic hepatitis B"],"prefix":"10.1007","volume":"11","author":[{"given":"Tao","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aichao","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenmin","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiming","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meifang","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jidong","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoping","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Detlef","family":"Schuppan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin","family":"Ning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,6,20]]},"reference":[{"issue":"1264\u20131273","key":"9803_CR1","first-page":"e1261","volume":"142","author":"HB El-Serag","year":"2012","unstructured":"El-Serag HB. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology. 2012;142(1264\u20131273):e1261.","journal-title":"Gastroenterology"},{"issue":"Suppl 3","key":"9803_CR2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3851\/IMP1620","volume":"15","author":"A Bertoletti","year":"2010","unstructured":"Bertoletti A, Maini MK, Ferrari C. The host-pathogen interaction during HBV infection: immunological controversies. Antivir Ther. 2010;15(Suppl 3):15\u201324.","journal-title":"Antivir Ther"},{"key":"9803_CR3","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1016\/j.jhep.2016.02.021","volume":"64","author":"M Levrero","year":"2016","unstructured":"Levrero M, Zucman-Rossi J. Mechanisms of HBV-induced hepatocellular carcinoma. J Hepatol. 2016;64:S84\u2013101.","journal-title":"J Hepatol"},{"key":"9803_CR4","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1136\/gutjnl-2011-301073","volume":"61","author":"A Bertoletti","year":"2012","unstructured":"Bertoletti A, Ferrari C. Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection. Gut. 2012;61:1754\u201364.","journal-title":"Gut"},{"key":"9803_CR5","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.jcmgh.2015.09.004","volume":"1","author":"B Rehermann","year":"2015","unstructured":"Rehermann B. Natural killer cells in viral hepatitis. Cell Mol Gastroenterol Hepatol. 2015;1:578\u201388.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"9803_CR6","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.clim.2012.12.013","volume":"146","author":"T Chen","year":"2013","unstructured":"Chen T, Zhu L, Zhou Y, Pi B, Liu X, Deng G, et al. KCTD9 contributes to liver injury through NK cell activation during hepatitis B virus-induced acute-on-chronic liver failure. Clin Immunol. 2013;146:207\u201316.","journal-title":"Clin Immunol"},{"key":"9803_CR7","doi-asserted-by":"crossref","first-page":"466","DOI":"10.4049\/jimmunol.0900687","volume":"184","author":"Y Zou","year":"2010","unstructured":"Zou Y, Chen T, Han M, Wang H, Yan W, Song G, et al. Increased killing of liver NK cells by Fas\/Fas ligand and NKG2D\/NKG2D ligand contributes to hepatocyte necrosis in virus-induced liver failure. J Immunol. 2010;184:466\u201375.","journal-title":"J Immunol"},{"key":"9803_CR8","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1128\/AAC.45.12.3381-3386.2001","volume":"45","author":"Z Zidek","year":"2001","unstructured":"Zidek Z, Frankova D, Holy A. Activation by 9-(R)-[2-(phosphonomethoxy)propyl]adenine of chemokine (RANTES, macrophage inflammatory protein 1alpha) and cytokine (tumor necrosis factor alpha, interleukin-10 [IL-10], IL-1beta) production. Antimicrob Agents Chemother. 2001;45:3381\u20136.","journal-title":"Antimicrob Agents Chemother"},{"key":"9803_CR9","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jhep.2010.07.009","volume":"54","author":"ET Tjwa","year":"2011","unstructured":"Tjwa ET, van Oord GW, Hegmans JP, Janssen HL, Woltman AM. Viral load reduction improves activation and function of natural killer cells in patients with chronic hepatitis B. J Hepatol. 2011;54:209\u201318.","journal-title":"J Hepatol"},{"key":"9803_CR10","doi-asserted-by":"crossref","first-page":"e1001227","DOI":"10.1371\/journal.ppat.1001227","volume":"6","author":"D Peppa","year":"2010","unstructured":"Peppa D, Micco L, Javaid A, Kennedy PT, Schurich A, Dunn C, et al. Blockade of immunosuppressive cytokines restores NK cell antiviral function in chronic hepatitis B virus infection. PLoS Pathog. 2010;6:e1001227.","journal-title":"PLoS Pathog"},{"key":"9803_CR11","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1056\/NEJMoa066422","volume":"357","author":"CL Lai","year":"2007","unstructured":"Lai CL, Gane E, Liaw YF, Hsu CW, Thongsawat S, Wang Y, et al. Telbivudine versus lamivudine in patients with chronic hepatitis B. N Engl J Med. 2007;357:2576\u201388.","journal-title":"N Engl J Med"},{"key":"9803_CR12","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0168-8278(03)00292-7","volume":"39","author":"C Boni","year":"2003","unstructured":"Boni C, Penna A, Bertoletti A, Lamonaca V, Rapti I, Missale G, et al. Transient restoration of anti-viral T cell responses induced by lamivudine therapy in chronic hepatitis B. J Hepatol. 2003;39:595\u2013605.","journal-title":"J Hepatol"},{"key":"9803_CR13","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s10875-011-9509-7","volume":"31","author":"N TrehanPati","year":"2011","unstructured":"TrehanPati N, Kotillil S, Hissar SS, Shrivastava S, Khanam A, Sukriti S, et al. Circulating Tregs correlate with viral load reduction in chronic HBV-treated patients with tenofovir disoproxil fumarate. J Clin Immunol. 2011;31:509\u201320.","journal-title":"J Clin Immunol"},{"key":"9803_CR14","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/hep.22419","volume":"48","author":"A Evans","year":"2008","unstructured":"Evans A, Riva A, Cooksley H, Phillips S, Puranik S, Nathwani A, et al. Programmed death 1 expression during antiviral treatment of chronic hepatitis B: impact of hepatitis B e-antigen seroconversion. Hepatology. 2008;48:759\u201369.","journal-title":"Hepatology"},{"key":"9803_CR15","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.antiviral.2011.04.008","volume":"91","author":"Y Chen","year":"2011","unstructured":"Chen Y, Li X, Ye B, Yang X, Wu W, Chen B, et al. Effect of telbivudine therapy on the cellular immune response in chronic hepatitis B. Antivir Res. 2011;91:23\u201331.","journal-title":"Antivir Res"},{"key":"9803_CR16","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1002\/hep.26489","volume":"58","author":"Y Li","year":"2013","unstructured":"Li Y, Ma S, Tang L, Wang W, Huang X, Lai Q, et al. Circulating chemokine (C-X-C Motif) receptor 5(+) CD4(+) T cells benefit hepatitis B e antigen seroconversion through IL-21 in patients with chronic hepatitis B virus infection. Hepatology. 2013;58:1277\u201386.","journal-title":"Hepatology"},{"key":"9803_CR17","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1002\/hep.28155","volume":"62","author":"C Boni","year":"2015","unstructured":"Boni C, Lampertico P, Talamona L, Giuberti T, Invernizzi F, Barili V, et al. Natural killer cell phenotype modulation and natural killer\/T-cell interplay in nucleos(t)ide analogue-treated hepatitis e antigen-negative patients with chronic hepatitis B. Hepatology. 2015;62:1697\u2013709.","journal-title":"Hepatology"},{"key":"9803_CR18","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1002\/hep.27323","volume":"61","author":"B Rehermann","year":"2015","unstructured":"Rehermann B, Bertoletti A. Immunological aspects of antiviral therapy of chronic hepatitis B virus and hepatitis C virus infections. Hepatology. 2015;61:712\u201321.","journal-title":"Hepatology"},{"issue":"Suppl 1","key":"9803_CR19","first-page":"24","volume":"17","author":"ZG Wu","year":"2010","unstructured":"Wu ZG, Yan WM, Guo W, Chen T, Zou Y, Wang HW, et al. Telbivudine preserves T-helper 1 cytokine production and downregulates programmed death ligand 1 in a mouse model of viral hepatitis. J Viral Hepat. 2010;17(Suppl 1):24\u201333.","journal-title":"J Viral Hepat"},{"key":"9803_CR20","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.immuni.2004.06.020","volume":"21","author":"B Meresse","year":"2004","unstructured":"Meresse B, Chen Z, Ciszewski C, Tretiakova M, Bhagat G, Krausz TN, et al. Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity. 2004;21:357\u201366.","journal-title":"Immunity"},{"key":"9803_CR21","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.cyto.2008.01.003","volume":"42","author":"C Zhang","year":"2008","unstructured":"Zhang C, Zhang J, Niu J, Tian Z. Interleukin-15 improves cytotoxicity of natural killer cells via up-regulating NKG2D and cytotoxic effector molecule expression as well as STAT1 and ERK1\/2 phosphorylation. Cytokine. 2008;42:128\u201336.","journal-title":"Cytokine"},{"key":"9803_CR22","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jhep.2012.09.029","volume":"58","author":"L Micco","year":"2013","unstructured":"Micco L, Peppa D, Loggi E, Schurich A, Jefferson L, Cursaro C, et al. Differential boosting of innate and adaptive antiviral responses during pegylated-interferon-alpha therapy of chronic hepatitis B. J Hepatol. 2013;58:225\u201333.","journal-title":"J Hepatol"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12072-017-9803-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-017-9803-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-017-9803-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,9,20]],"date-time":"2017-09-20T06:23:16Z","timestamp":1505888596000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12072-017-9803-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,20]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["9803"],"URL":"https:\/\/doi.org\/10.1007\/s12072-017-9803-4","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,20]]}}}